American Journal of Dermatopathology · 2006 · 242 citations · 55 references
MedicineOncologyPathologyCellular PathologyNeoplasiaTumor PathologyImmunohistochemistryLung CancerMalignant NeoplasmsMerkel Cell CarcinomaTumor AntigensTumor MarkersDiagnostic ImmunohistochemistryImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingLung Cancer PathologyMerkel Cell Carcinoma HistopathologyNeuron-specific Enolase
We assessed the usefulness of several immunohistochemical stains in distinguishing these two neoplasms, including cytokeratin 7, cytokeratin 20 (CK20), neuron-specific enolase, chromogranin, synaptophysin, neurofilaments (NF), thyroid-transcription factor-1 (TTF-1), CD56 antigen, S-100 protein, vimentin, c-erbB-2 oncoprotein, and CD117 antigen. All 13 cases of Merkel cell carcinoma evaluated were positive for CK20, and negative for TTF-1. Twelve of 13 Merkel cell carcinoma cases were positive for NF. Eleven of 13 cases of small cell lung carcinoma were positive for TTF-1. All small cell lung carcinoma cases were negative for NF, and all but one were negative for CK20. In terms of the remaining antigens, there were no differences of significance between the two neoplasms. These findings suggest that a set of three immunohistochemical stains, including CK20, NF, and TTF-1, is useful in affording a distinction between Merkel cell carcinoma and small cell lung carcinoma.
55
Trabecular Carcinoma of the Skin
Cyril Toker · Archives of Dermatology · 1972 · 1.4K citations
Medicine, Dermatology, Oncology +17
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
R. Moll, A D Lowe, Jürgen Laufer et al. · PubMed · 1992 · 813 citations
Trabecular carcinoma of the skin. An ultrastructural study
Chik‐Kwun Tang, Cyril Toker · Cancer · 1978 · 542 citations